Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysis

International Immunopharmacology

Volumn 54, Issue , 2018, Pages 198-209

  Yin, Ju ^a   Xu, Baoping ^a   Zeng, Xiantao ^b,c   Shen, Kunling ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Broncho Vaxom; Efficacy; Meta analysis; Pediatric recurrent respiratory infections; Safety

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BRONCHO-VAXOM; CELL EXTRACT; IMMUNOLOGICAL ADJUVANT;

ANTIBIOTIC THERAPY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COUGHING; DRUG EFFICACY; DRUG SAFETY; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW; WHEEZING; ANIMAL; ANTIBODY PRODUCTION; CHILD; IMMUNOLOGY; RECURRENT DISEASE; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODY FORMATION; ANTIVIRAL AGENTS; CELL EXTRACTS; CHILD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES;

EID: 85034087196     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2017.10.032     Document Type: Review

References (72)

1. Chinese Pediatric Society of Chinese Medical Association, The clinical concept and treatment principle of recurrent respiratory tract infections. Chin. J. Pediatr. 2:46 (2008), 108–110, 10.3321/j.issn:0578-1310.2008.02.008.
2. Damoiseaux, R.A. et al., NHG-Standaard Otitis media acuta bij kinderen (Trans.) NHG standard Otitis Media in children Huisarts Wet 12:49 (2006), 615–621.
3. Schaad, U.B., Esposito, S., Razi, C., Diagnosis and management of recurrent respiratory tract infections in children: a practical guide. Arch. Pediatr. Infect. Dis., 4(1), 2016, e31039, 10.5812/pedinfect.31039.
4. Ozkan, H. et al., IgA and/or IgG subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage. J Investig Allergol Clin Immunol 15:1 (2005), 69–74.
5. David, J.R., Rosen, F.S., Deficiencies in Immunoglobulins and Cell-mediated Immunity [CD-ROM]. 2000, Scientific American Medicine, New York.
6. Koatz, A.M. et al., Clinical and immunological benefits of OM-85 bacterial lysate in patients with allergic rhinitis, asthma, and COPD and recurrent respiratory infections. Lung 194:4 (2016), 687–697, 10.1007/s00408-016-9880-5.
7. Zelle-Rieser, C. et al., A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83 + immunostimulatory dendritic cells. Immunol. Lett. 76:1 (2001), 63–67, 10.1016/S0165-2478(00)00326-6.
8. Huber, M., Mossmann, H., Bessler, W.G., Th1-orientated immunological properties of the bacterial extract OM-85-BV. Eur. J. Med. Res. 10:5 (2005), 209–217.
9. Zeng, X. et al., The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J. Evid. Based Med. 8:1 (2015), 2–10, 10.1111/jebm.12141.
10. Li, J., Bao, J., Bao, Y., Bacterial lysates OM-85BV in children with asthma and nasal allergy symptoms. J. Pediatr. Pharm. 23:1 (2017), 7–10, 10.13407/j.cnki.jpp.1672-108X.2017.01.003.
11. Luo, S., Ma, C., Efficacy of bacterial lysate on recurrent respiratory tract infections in children. Chin. Foreign Med. Res. 14:26 (2016), 42–44, 10.14033/j.cnki.cfmr.2016.26.022.
12. Ye, Y., Jiang, P., Effect of Broncho-Vaxom on immune mechanism and inflammatory mechanism of recurrent respiratory tract infections in children and its efficacy. Clin. Educ. Gen. Pract. 14:4 (2016), 424–426, 10.13558/j.cnki.issn1672-3686.2016.04.018.
13. Yin, L., Chen, H., Feng, X., Clinical study on bacterial lysates combined with budesonide in treatment of recurrent respiratory tract infection in children. Drugs Clin. 31:8 (2016), 1273–1277.
14. Gu, S., Wu, C., Xie, G., Efficacy of bacterial lysates in the adjuvant therapy for children with recurrent respiratory tract infections. Chin. J. Pract. Pediatr. 30:3 (2015), 207–210.
15. Liu, F. et al., Clinical effect analysis of Bronchovaxom in the treatment of children with recurrent respiratory tract infections. Chin. J. Nosocomiol. 25:4 (2015), 942–944.
16. Zhang, W., Efficacy of Broncho-vaxom in the adjuvant therapy for children with recurrent respiratory tract infections. Guide China Med. 13:13 (2015), 70–71, 10.15912/j.cnki.gocm.2015.13.050.
17. Zhu, H., Zhang, H., Hu, W., Clinical observation on 60 cases of recurrent respiratory tract infections in children treated by Bronchovaxom combined with routine treatment. China Prac. Med. 10:7 (2015), 140–141, 10.14163/j.cnki.11-5547/r.2015.07.098.
18. Zhuang, S. et al., Compliance of Bronchovaxom in treatment of recurrent respiratory tract infections. IMHGN 21:14 (2015), 1948–1950, 10.3760/cma.j.issn.1007-1245.2015.14.003.
19. Liao, J., Zhang, T., Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection. Chin. J. Contemp. Pediatr. 16:5 (2014), 508–512, 10.7499/j.issn.1008-8830.2014.05.013.
20. Shen, Y., Effect and mechanism of Broncho-Vaxom in the treatment of recurrent respiratory tract infections in children. J. Pediatr. Pharm. 20:1 (2014), 32–34, 10.13407/j.cnki.jpp.1672-108x.2014.01.015.
21. Su, L., Liu, Y., Clinical analysis of treatment for children with recurrent respiratory tract infections. Chin. J. Nosocomiol. 24:18 (2014), 4625–4626, 10.11816/cn.ni.2014-134498.
22. Li, G., Efficacy of Bronchovaxom in the treatment of children with recurrent respiratory tract infections. China Health Care Nutr., 7(7), 2013, 629.
23. Lu, L., Efficacy of Broncho-Vaxom in preventing or treating recurrent respiratory tract infections in children. China Health Care Nutr. 33:5 (2013), 2627–2628, 10.3969/j.issn.1004-7484(x).2013.05.482.
24. Chen, G., Lan, X., Ye, H., Efficacy of Bronchovaxom in the treatment of children with recurrent respiratory tract infections. China Prac. Med. 8:1 (2013), 163–164, 10.3969/j.issn.1673-7555.2013.01.128.
25. Huang, X., Diagnosis and treatment of infant respiratory tract infection in community outpatient department. Chin. Rural Health Serv. Adm. 32:3 (2012), 316–317.
26. Ji, H., Efficacy of Bronchovaxom in the treatment of children with recurrent respiratory tract infections. World Health Dig. Med. Period 9:33 (2012), 108–109, 10.3969/j.issn.1672-5085.2012.33.096.
27. Li, J., Hao, Y., Clinical analysis of 30 cases of children with recurrent respiratory tract infections treated by bacterial lysate. China Mod. Med. 19:3 (2012), 54–55, 10.3969/j.issn.1674-4721.2012.03.027.
28. Lou, Z., Efficacy of Bronchovaxom in the treatment of children with recurrent respiratory tract infections. Hebei Med. 34:5 (2012), 726–727, 10.3969/j.issn.1002-7386.2012.05.047.
29. Zuo, M. et al., Effect observation of bacterial lysates in the treatment of iron deficiency anemia and recurrent respiratory infections in children. J. Pediatr. Pharm. 18:2 (2012), 16–19, 10.3969/j.issn.1672-108X.2012.02.007.
30. Zhao, Y., Efficacy of Broncho-Vaxom (8 kinds of bacterial lysates) in the treatment of children with recurrent respiratory tract infections. Chin. Foreign Med. Res. 10:35 (2012), 121–122, 10.14033/j.cnki.cfmr.2012.35.114.
31. Zhuang, D., Zhao, F., Li, Y., Effect of Broncho-vaxom on the mucosal immune function in children with recurrent respiratory tract infection. China Med. Her. 9:32 (2012), 100–101, 10.3969/j.issn.1673-7210.2012.32.040.
32. Chao, M. et al., Efficacy of bacterial lysates in the adjuvant therapy for children with recurrent respiratory tract infections. Nanchang Da Xue Xue Bao (Med. Sci.) 51:4 (2011), 74–75, 10.3969/j.issn.1000-2294.2011.04.023.
33. Hu, B. et al., Clinical efficacy of fluticasone plus combined with bacterial lysates in treatment of children with asthma. China Mod. Doct. 49:16 (2011), 83–85, 10.3969/j.issn.1673-9701.2011.16.039.
34. Liang, A., Zhang, Y., Wang, F., Clinical observation on 73 cases of repeated respiratory tract infections treated by Broncho-Vaxom. J. Clin. Pulm. Med. 16:2 (2011), 284–285, 10.3969/j.issn.1009-6663.2011.02.070.
35. Zhang, Y., Sun, Y., Zhao, X., Clinical research on bacterial lysates in prevention of wheezing onset induced by viral infection among preschool children. Matern. Child Health Care China 26:25 (2011), 3904–3906.
36. Fu, H., Lin, Z., Efficacy of Broncho-Vaxom in the treatment of children with recurrent respiratory respiratory tract infections. World Health Dig. Med. Period 7:8 (2010), 58–59, 10.3969/j.issn.1672-5085.2010.08.049.
37. Gao, Y. et al., Therapeutic efficacy of bacterial lysates and montelukast treatment in children with intermittent asthma. Chin. J. Clin. Pharmacol. Ther. 15:5 (2010), 547–550.
38. Song, M., Efficacy of bacterial lysates in the treatment of children with recurrent respiratory tract infections. Jilin Yi Xue, 31(24), 2010, 4055, 10.3969/j.issn.1004-0412.2010.24.029.
39. Ye, G., Clinical observation on 50 cases of repeated respiratory tract infections in children treated by Broncho-Vaxom. Strait Pharm. J. 22:3 (2010), 115–116, 10.3969/j.issn.1006-3765.2010.03.053.
40. Razi, C.H. et al., The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J. Allergy Clin. Immunol. 126:4 (2010), 763–769, 10.1016/j.jaci.2010.07.038.
41. Liao, Y., Efficacy of Broncho-Vaxom in children with recurrent respiratory tract infections. China Mod. Doct. 47:7 (2009), 81–82, 10.3969/j.issn.1673-9701.2009.07.041.
42. Mo, H., Xu, A., Effectiveness of Broncho-Vaxom in treating repeated respiratory tract infection in children. J. Mod. Med. Health 25:18 (2009), 2758–2760.
43. Zhang, A., Zhang, L., Fu, S., Effect of Broncho-vaxom on repeatedly respiratory infection in children. Prog. Mod. Biomed. 9:19 (2009), 3690–3691, 10.13241/j.cnki.pmb.2009.19.038.
44. Zhao, X. et al., Effect of bacterial lysates on humoral immunity and clinical therapy in children with recurrent respiratory tract infection. Zhong Nan Yao Xue 7:12 (2009), 946–948.
45. Li, J. et al., Observation on the therapeutic effect of Broncho-Vaxom in treating repeated respiratory tract infections. Acta Acad. Med. CPAF 17:3 (2008), 212–213.
46. Tan, Y., Efficacy of oral bacterial lysates in children with bronchial asthma complicated with recurrent respiratory tract infections. China Mod. Doct. 46:18 (2008), 186–187, 10.3969/j.issn.1673-9701.2008.18.103.
47. Wu, Y. et al., Efficacy of Broncho-Vaxom in children with recurrent respiratory tract infections. Clin. Focus 23:9 (2008), 659–660, 10.3969/j.issn.1004-583X.2008.09.022.
48. Huang, L. et al., Efficacy of Broncho-Vaxom and the changes of immune function and normal respiratory flora in children with recurrent respiratory tract infection. Hebei Med. J. 29:10 (2007), 1088–1090, 10.3969/j.issn.1002-7386.2007.10.027.
49. Yuan, J., Chen, X., Effect of Broncho-Vaxom on bronchial asthma with recurrent respiratory tract infections. Zhejiang Clin. Med. J., 9(5), 2007, 627, 10.3969/j.issn.1008-7664.2007.05.033.
50. Zhang, H. et al., Efficacy and safety of Broncho-Vaxom in preventing recurrent respiratory tract infection in infants with asthma. J. Pract. Med. 23:21 (2007), 3427–3428, 10.3969/j.issn.1006-5725.2007.21.060.
51. Gao, J., Yu, C., Efficacy of Broncho-Vaxom in children with recurrent respiratory tract infections. Hebei Med. J., 28(4), 2006, 285, 10.3969/j.issn.1002-7386.2006.04.028.
52. Del-Rio-Navarro, B.E. et al., Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels. Allergol Immunopathol (Madr) 31:1 (2003), 7–13, 10.1016/S0301-0546(03)79158-7.
53. Schaad, U.B., Mutterlein, R., Goffin, H., Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 122:6 (2002), 2042–2049, 10.1378/chest.122.6.2042.
54. Gutierrez-Tarango, M.D., Berber, A., Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 119:6 (2001), 1742–1748, 10.1378/chest.119.6.1742.
55. Zhang, T., Liang, H., Fan, Y., Efficacy of Broncho-Vaxom in children with recurrent respiratory respiratory tract infections. J. Pract. Med. 16:9 (2000), 778–779, 10.3969/j.issn.1006-5725.2000.09.039.
56. Jara-Perez, J.V., Berber, A., Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin. Ther. 22:6 (2000), 748–759, 10.1016/S0149-2918(00)90008-0.
57. Gomez, B.D. et al., Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children. Allergol Immunopathol (Madr) 26:1 (1998), 17–22.
58. Paupe, J., Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 58:3–4 (1991), 150–154, 10.1159/000195916.
59. Zagar, S., Lofler-Badzek, D., Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial. ORL J. Otorhinolaryngol. Relat. Spec. 50:6 (1988), 397–404, 10.1159/000276020.
60. Schaad, U.B., Farine, J.C., Fux, T., Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children. Helv. Paediatr. Acta 41:1–2 (1986), 7–17.
61. Ahrens, J., Multicentre double-blind clinical trial with broncho-vaxom in children. Therapiewoche 34:22 (1984), 3469–3475.
62. Maestroni, G.J., Losa, G.A., Clinical and immunobiological effects of an orally administered bacterial extract. Int. J. Immunopharmacol. 6:2 (1984), 111–117, 10.1016/0192-0561(84)90005-5.
63. World Health Organization, Acute respiratory infections: the forgotten pandemic. Bull. World Health Organ. 76:1 (1998), 101–103 (105-7).
64. Gates, G.A., Cost-effectiveness considerations in otitis media treatment. Otolaryngol. Head Neck Surg. 114:4 (1996), 525–530, 10.1016/S0194-59989670243-7.
65. Yang, H., Sun, S., Etiology and treatment of recurrent respiratory tract infection in children. Hebei Bei Fang Xue Yuan Xue Bao (Yi Xue Ban) 26:01 (2009), 66–68, 10.3969/j.issn.2095-1396.2009.01.028.
66. Yui, I. et al., Novel clinical features of recurrent human respiratory syncytial virus infections. J. Med. Virol. 86:9 (2014), 1629–1638, 10.1002/jmv.23809.
67. Rantala, A., Jaakkola, J.J., Jaakkola, M.S., Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens. PLoS One, 8(7), 2013, e68582, 10.1371/journal.pone.0068582.
68. Pu, F. et al., Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clin. Interv. Aging 12 (2017), 1223–1231, 10.2147/CIA.S141518.
69. Feng, X.B., Yang, X.Q., Shen, J., Influence of iron deficiency on serum IgG subclass and pneumococcal polysaccharides specific IgG subclass antibodies. Chin. Med. J. 107:11 (1994), 813–816.
70. Steurer-Stey, C. et al., Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review. Eur. J. Pediatr. 166:4 (2007), 365–376, 10.1007/s00431-006-0248-3.
71. Schaad, U.B., OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J. Pediatr. 6:1 (2010), 5–12, 10.1007/s12519-010-0001-x.
72. Ma, J. et al., Effects of bacterial lysates in patients with recurrent respiratory tract infections: a meta-analysis. Chin. J. Drug Eval. 31:05 (2014), 284–288, 10.3969/j.issn.2095-3593.2014.05.010.